What Is EDSS? Scores, Ranges, and Clinical Use

The EDSS, or Expanded Disability Status Scale, is a scoring system neurologists use to measure how much multiple sclerosis (MS) has affected a person’s body and daily functioning. It runs from 0 to 10 in half-point increments, where 0 means a completely normal neurological exam and 10 represents death from MS. If you’ve been diagnosed with MS or are reading about a clinical trial, this is likely the number your neurologist uses to track your disease over time.

How the Score Is Determined

A neurologist calculates your EDSS by performing a standard neurological exam that evaluates eight functional systems in your body: muscle strength and movement (pyramidal), coordination and balance (cerebellar), brainstem functions like swallowing and eye movement, sensation, bowel and bladder control, vision, and two aspects of mental function. Each system gets its own sub-score based on what the exam reveals.

Those sub-scores are then combined with an assessment of how far you can walk and whether you need any assistive devices. The whole process traditionally takes around 30 minutes, though newer streamlined approaches can cut that roughly in half. Your neurologist may repeat this exam at regular intervals to see whether your score has changed over time.

What Each Score Range Means

The scale is easier to understand when broken into broad ranges tied to real-life function.

0 to 1.5: No disability. Your neurological exam might show minor signs, like a slightly abnormal reflex, but nothing that affects your daily life.

2.0 to 3.5: Minimal to moderate disability in one or more functional systems. You’re fully ambulatory and can manage daily activities, though a neurologist can detect measurable deficits on exam.

4.0 to 4.5: This is where disability becomes more noticeable in daily life, but you can still walk without a cane or other aid. At 4.0, you can walk more than 500 meters without resting. At 4.5, that drops to about 300 meters, and you may need some adjustments to work a full day.

5.0 to 5.5: Walking distance shortens significantly. At 5.0, you can walk roughly 200 meters without aid or rest. At 5.5, it’s about 100 meters. Disability at this level is severe enough to interfere with working full days or completing all daily activities independently.

6.0 to 6.5: You now need assistive devices. At 6.0, you need a cane or single crutch to walk about 100 meters. At 6.5, you need two canes or crutches to walk about 20 meters without stopping.

7.0 to 7.5: Walking is essentially no longer possible, even with aids. At 7.0, you can propel a standard wheelchair yourself and transfer independently, spending much of the day up and about in the chair. At 7.5, you may need help transferring and could require a motorized wheelchair.

8.0 to 9.5: These scores describe increasing dependence. At 8.0, you’re mostly restricted to a bed or chair but still have effective use of your arms and can handle many self-care tasks. By 9.0, you’re bed-bound but can communicate and eat. At 9.5, you can no longer communicate effectively or swallow.

Why Walking Distance Dominates the Scale

One of the most important things to understand about EDSS is that once your score climbs above 4.0, it’s largely determined by how far you can walk and what kind of support you need to do it. The jump from 4.0 to 6.5, for example, maps almost directly to declining walking distance: 500 meters, then 300, 200, 100, and finally 20 meters with bilateral support.

This heavy emphasis on walking is also the scale’s biggest criticism. Cognitive decline, fatigue, upper limb function, and bowel or bladder problems can all worsen significantly without budging your EDSS score. A person could experience meaningful deterioration in memory, hand dexterity, or daily energy levels and still appear “stable” on the EDSS because their walking distance hasn’t changed. For people with secondary progressive MS or those already scoring above 4.0, the scale can paint an incomplete picture of how they’re actually doing.

How EDSS Is Used in Clinical Trials

Nearly every major MS drug trial uses EDSS to measure whether a treatment slows disability progression. The standard endpoint is called “confirmed disability progression,” which means your EDSS score increases by a set amount and stays there for at least 3 or 6 months. The required increase depends on where you started: if your baseline score was 0, you need to jump at least 1.5 points. For baseline scores between 1.0 and 5.0, the threshold is a 1-point increase. For scores of 5.5 or higher, even a half-point increase counts, because at that range, small changes on the scale represent meaningful losses in independence.

When your neurologist tells you a new treatment “reduced disability progression by 30%,” that figure almost certainly came from tracking EDSS changes across hundreds or thousands of patients over one to two years.

Other Tools That Fill the Gaps

Because of the EDSS’s blind spots, researchers and clinicians sometimes pair it with other measures. The Multiple Sclerosis Functional Composite (MSFC), for example, includes a timed cognitive test alongside measures of hand dexterity and walking speed. Studies have found the MSFC captures cognitive deficits that the EDSS misses entirely, which matters for real-world tasks like driving. Your care team might also use patient-reported questionnaires about fatigue, quality of life, or work capacity to get a fuller picture of how MS is affecting you beyond what a walking test can show.

The EDSS remains the most widely used and recognized disability measure in MS, and knowing your score gives you a shared language with your neurologist. Just keep in mind that it captures one dimension of the disease particularly well, while other important dimensions, like thinking speed, hand function, and energy levels, may need separate attention.